Clinical Trials Browser

Phase 1 × Lung Neoplasms × toripalimab × Clear all

NCT02836834 2019-10-22

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors

Phase 1 Unknown

LymphoidThoracic

Lung Neoplasms, Lymphoma